EMA grants marketing authorisation for Zubsolv for opioid dependence
The EMA has granted a Marketing Authorization for Zubsolv, a…
The EMA has granted a Marketing Authorization for Zubsolv, a novel rapidly-disintegrating treatment option for opioid dependence...